Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 19, 2007
J Am Soc Nephrol 19: 213-216, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007080854

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007080854v1
19/2/213    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moe, S. M.
Right arrow Articles by Chen, N. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moe, S. M.
Right arrow Articles by Chen, N. X.

Science in Renal Medicine

Mechanisms of Vascular Calcification in Chronic Kidney Disease

Sharon M. Moe and Neal X. Chen

Department of Medicine, Indiana University, Indianapolis, Indiana

Correspondence: Dr. Sharon M. Moe, Professor of Medicine, Department of Medicine, Indiana University, 1001 W. 10th Street, OPW 526, Indianapolis, IN 46202. Phone: 317-278-2868; Fax: 317-278-2860; E-mail: smoe{at}iupui.edu

Vascular calcification is common in chronic kidney disease and associated with increased morbidity and mortality. Its mechanism is multifactorial and incompletely understood. Patients with chronic kidney disease are at risk for vascular calcification because of multiple risk factors that induce vascular smooth muscle cells to change into a chondrocyte or osteoblast-like cell; high total body burden of calcium and phosphorus due to abnormal bone metabolism; low levels of circulating and locally produced inhibitors; impaired renal excretion; and current therapies. Together these factors increase risk and complicate the management of vascular calcification.




This article has been cited by other articles:


Home page
HypertensionHome page
J.-S. Shao, S.-L. Cheng, J. Sadhu, and D. A. Towler
Inflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective
Hypertension, March 1, 2010; 55(3): 579 - 592.
[Full Text] [PDF]


Home page
NDT PlusHome page
Y. Oyama, J. J. Kazama, M. Fukagawa, Y. Arakawa, and I. Ezuka
Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism
NDT Plus, February 1, 2010; 3(1): 64 - 67.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. L. Ford, L. A. Tomlinson, E. R. Smith, C. Rajkumar, and S. G. Holt
Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4
Nephrol. Dial. Transplant., January 14, 2010; (2010) gfp723v1.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Raggi, S. Vukicevic, R. M. Moyses, K. Wesseling, and D. M. Spiegel
Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(Supplement_1): S31 - S40.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C J Ferro, C D Chue, R P Steeds, and J N Townend
Is lowering phosphate exposure the key to preventing arterial stiffening with age?
Heart, November 1, 2009; 95(21): 1770 - 1772.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. G. Hage, R. Venkataraman, G. J. Zoghbi, G. J. Perry, A. M. DeMattos, and A. E. Iskandrian
The scope of coronary heart disease in patients with chronic kidney disease.
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2129 - 2140.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. N. Foley
Phosphate Levels and Cardiovascular Disease in the General Population
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1136 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. M. Moe
Vascular Calcification: The Three-Hit Model
J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1162 - 1164.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. C. Palmer, J. C. Craig, and G. F. M. Strippoli
Taking aim at targets
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1358 - 1361.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Villa-Bellosta and V. Sorribas
Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 761 - 766.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Jean, E. Bresson, J.-C. Terrat, T. Vanel, J.-M. Hurot, C. Lorriaux, B. Mayor, and C. Chazot
Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 948 - 955.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. H. Ix, I. H. De Boer, C. A. Peralta, K. L. Adeney, D. A. Duprez, N. S. Jenny, D. S. Siscovick, and B. R. Kestenbaum
Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA
Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Eknoyan
Salivary Phosphorus Binding: A Novel Approach to Control Hyperphosphatemia
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 460 - 462.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al.
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells
Cardiovasc Res, February 1, 2009; 81(2): 260 - 268.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
T. B. Drueke
Arterial Intima and Media Calcification: Distinct Entities with Different Pathogenesis or All the Same?
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1583 - 1584.
[Full Text] [PDF]


Home page
CJASNHome page
K. Amann
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1599 - 1605.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. Danziger
Vitamin K-dependent Proteins, Warfarin, and Vascular Calcification
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1504 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Palmer and G. Strippoli
Reply: Vitamin D compounds in chronic kidney disease: change may be needed for good!
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1789 - 1792.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP